AffaMed Therapeutics
PrivateLast Round
Series B
Mar 30, 2021
Total Funding Raised
$250M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AffaMed Therapeutics is a biopharmaceutical company that develops and commercializes transformative pharmaceutical products for ophthalmic, neurological, and psychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AffaMed Therapeutics Comparables
Compare AffaMed Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arctic Vision | 88% | |
| Allgenesis Biotherapeutics Inc. | 80% | |
| Ocumension Therapeutics | 78% |
AffaMed Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 30, 2021 | ||||
| Series A | Feb 1, 2019 |
AffaMed Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lake Bleu Capital | Series B |
| CBC Group | Series B, Series A |
| Superstring Capital Management | Series B |
| Fountainhead Partners | Series B |
| Partners Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 8, 4x the trailing average.
- Jul 20, 2026
Open roles increased from 0 to 8, representing 25% of headcount.
AffaMed Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AffaMed Therapeutics's valuation, stock price, and market status.
Is AffaMed Therapeutics a public or private company?
AffaMed Therapeutics is a private company.
What is the current stock price of AffaMed Therapeutics?
AffaMed Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is AffaMed Therapeutics worth (valuation)?
Valuation information for AffaMed Therapeutics is not publicly available.
Can I buy AffaMed Therapeutics stock?
AffaMed Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AffaMed Therapeutics's last funding round?
Funding round information for AffaMed Therapeutics is not publicly available.
Who are the main investors in AffaMed Therapeutics?
Investor information for AffaMed Therapeutics is not publicly disclosed.
Will AffaMed Therapeutics IPO soon?
No public IPO plans have been announced for AffaMed Therapeutics.
How can I track AffaMed Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AffaMed Therapeutics's secondary market activity and sign up for updates.